For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated ...

If I’d gone flat after my mastectomy, I might be healthy now, but my breast implants led to more cancer, heart failure and years of pain.

Patients with BRCA-mutant breast cancer had a significantly higher risk of breast implant-associated anaplastic large-cell ...

Women with breast cancer who carry mutations in the BRCA1 or BRCA2 gene and undergo reconstruction with textured breast implants face a substantially higher risk of developing breast ...

This is the first large study to look at whether the BIA-ALCL occurrence is higher among women who have a BRCA mutation, which is also responsible for the onset of breast cancer in 5%–10% of cases.

St. Petersburg resident Lisa Medlen was diagnosed with anaplastic large cell lymphoma in January. The cancer is linked to textured breast implants. [ Christopher O'Donnell ] ...

HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy. Leukemia, 2025; DOI: 10.1038/s41375-025-02584-9 ...

The approval was based on data from the randomized, double-blind, placebo-controlled ECHELON-3 trial (ClinicalTrials.gov Identifier: NCT04404283), which included 230 patients with R/R LBCL who ...

The Food and Drug Administration (FDA) has approved Adcetris ® (brentuximab vedotin) in combination with lenalidomide and a rituximab product for adult patients with relapsed or refractory (R/R ...

UPDATE: In March 2023, the FDA issued a safety communication with updated information about squamous cell carcinoma (SCC) in the scar tissue (capsule) around breast implants. The March 2023 ...